Rare Disease Treatments
Pharmaceutical and biotech companies developing orphan drugs and therapies for rare diseases affecting small patient populations
Symbols
LLYLilly(Eli) & CoMarket Cap: $844.9B
ABBVAbbvie IncMarket Cap: $367.7B
NOVNNovartis AGMarket Cap: $294B
AMGNAMGEN Inc.Market Cap: $189.2B
NVONovo NordiskMarket Cap: $169.2B
BRMBristol-Myers Squibb Co.Market Cap: $119.4B
BMYBristol-Myers Squibb Co.Market Cap: $119.4B
VRTXVertex Pharmaceuticals, Inc.Market Cap: $110.8B
REGNRegeneron Pharmaceuticals, Inc.Market Cap: $79.2B
SNYSanofiMarket Cap: $57B
ARGXArgen X SEMarket Cap: $49.5B
EDGGold Fields LtdMarket Cap: $44.2B
ALNYAlnylam Pharmaceuticals IncMarket Cap: $42.7B
INSMInsmed IncMarket Cap: $33.4B
TAKTakeda Pharmaceutical CoMarket Cap: $30.7B
BDRXBiodexa Pharmaceuticals PlcMarket Cap: $30.3B
ZLABZai Lab LimitedMarket Cap: $29.2B
BIIBBiogen IncMarket Cap: $25.4B
UTHRUnited Therapeutics CorpMarket Cap: $25.1B
ROIVRoivant Sciences LtdMarket Cap: $20.2B